跳至主要内容
临床试验/EUCTR2006-003143-23-NL
EUCTR2006-003143-23-NL进行中(未招募)1 期

To study the cardiovasculair effects of vasodilatation by nifedipine (Adalat gastrointestinal therapeutic system) with or without plasma volume expansion with Voluven (colloid) in women with preeclampsia

St Radboud UMC0 个研究点目标入组 22 人开始时间: 2006年7月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • preeclampsia, gestational age 24- 34 weeks, singleton pregnancy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • known allergy to nifedipine, known cardiovasculair or renal- or liverpathology, previous treatment with antihypertensives or tocolytics, foetal distress necessitating delivery in less than 48 uur, imminent eclampsia, no informed consent from the patient or the doctor treating the patient, multiple pregnancy, unable to take tablets

研究者

发起方
St Radboud UMC

相似试验

To study the cardiovasculair effects of... | 临床试验